Technical guide. Pharmaceutical water systems 2026: Digitalization, sustainability and regulatory update
Water is one of the most relevant critical services in the pharmaceutical industry. Its transversal use (from the formulation […]
Pharmaceutical industry
Closing the cycle: From Risk Analysis (QbD) to Objective Evidence of operation
From healthcare design to documentary evidence In the two previous articles in this series of three technical publications we have
Pharmaceutical architecture, flows and HVAC systems
Where critical deviations are born (or avoided) In the previous article in this series of three technical publications we addressed
Design of pharmaceutical facilities under the QbD paradigm
In the pharmaceutical industry, the design of a facility is neither an architectural exercise nor mere regulatory compliance. Is
Profarma Plan 2025 2026. Having the Spanish pharmaceutical industry
The new Profarma 2025-2026 plan, presented by the Ministry of Industry, Tourism and Health, becomes a key piece inside
Preparing equipment and facilities for regulatory audits
In the highly regulated environment of the pharmaceutical industry, audits and regulatory inspections are a constant. The right one
Understand the stages of qualification and its impact on pharmaceutical quality
In the pharmaceutical industry, where the quality, patient safety and compliance with regulations are priority, qualification
The strategy behind the design of modern API facilities
The design of facilities for the production of active pharmaceutical ingredients (API)
Validation as a guarantee of control in control systems
In the pharmaceutical industry, guaranteeing the quality, safety and effectiveness of products is an absolute priority. To do this, I know
What are CIP and SIP systems and why are they essential in the pharmaceutical industry?
In the pharmaceutical industry, hygiene and sterility of process teams are critical factors to guarantee